Pfizer Raises 2026 Outlook: What it Means for Pharma ETFs

Pfizer has announced a significant upward revision to its 2026 financial projections, now anticipating revenues in the range of $62 billion to $64 billion. The company also provided an adjusted earnings per share forecast between $2.95 and $3.05. This updated…